Use of Entresto Sacubitril/Valsartan for the Treatment of Peripheral Arterial Disease

Summary

This study proposes the use of Entresto (sacubitril/valsartan) to test the effects on pain free walking duration on patients with peripheral arterial disease, a condition caused by decreased blood flow to the muscles in the legs.

Timeline

Start

2017-12-31

Primary completion

2018-11-01

Completion

2018-11-01

Outcome

Outcome not reported

Stopped (Enrollment): “Recruitment”

Drugs

Indications